Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Salvational Intervention With ICS/LABA for Reducing Chronic Obstructive Pulmonary Disease Exacerbation Under Severe Air Pollution (SIRCAP) in Beijing

NCT03083067 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03083067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03083067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Salvational Intervention With ICS/LABA for Reducing Chronic Obstructive Pulmonary Disease Exacerbation Under Severe Air Pollution (SIRCAP) in Beijing
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2017
Completion date
March 16, 2022
Enrollment
402 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

air pollution, copd exacerbation